Atomistry » Zinc » PDB 3e2d-3eb5 » 3e8r
Atomistry »
  Zinc »
    PDB 3e2d-3eb5 »
      3e8r »

Zinc in PDB 3e8r: Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor

Enzymatic activity of Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor

All present enzymatic activity of Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor:
3.4.24.86;

Protein crystallography data

The structure of Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor, PDB code: 3e8r was solved by P.Orth, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 42.41 / 1.90
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 74.722, 75.761, 102.985, 90.00, 90.00, 90.00
R / Rfree (%) 18.9 / 22.6

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor (pdb code 3e8r). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor, PDB code: 3e8r:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in 3e8r

Go back to Zinc Binding Sites List in 3e8r
Zinc binding site 1 out of 2 in the Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1

b:24.8
occ:1.00
O2 A:615486 2.0 15.3 0.4
NE2 A:HIS415 2.0 23.6 1.0
NE2 A:HIS405 2.0 20.6 1.0
NE2 A:HIS409 2.2 20.5 1.0
O4 A:INN4 2.2 19.2 0.6
O A:INN4 2.2 17.0 0.6
O4 A:615486 2.3 15.2 0.4
O A:HOH631 2.5 38.0 1.0
C3 A:615486 2.8 3.8 0.4
C A:INN4 2.8 42.5 0.6
N A:INN4 2.9 15.6 0.6
CE1 A:HIS415 3.0 23.8 1.0
CD2 A:HIS405 3.0 19.4 1.0
N2 A:615486 3.0 51.7 0.4
CD2 A:HIS409 3.0 20.3 1.0
CD2 A:HIS415 3.1 22.2 1.0
CE1 A:HIS405 3.1 21.0 1.0
CE1 A:HIS409 3.2 20.8 1.0
O A:HOH509 3.9 19.9 1.0
ND1 A:HIS415 4.1 24.4 1.0
CG A:HIS405 4.1 19.8 1.0
ND1 A:HIS405 4.2 21.2 1.0
CG A:HIS415 4.2 22.6 1.0
C21 A:615486 4.2 37.5 0.4
CG A:HIS409 4.2 17.9 1.0
O A:HOH632 4.3 38.3 1.0
C0 A:INN4 4.3 20.7 0.6
ND1 A:HIS409 4.3 19.3 1.0
O A:HOH634 4.3 39.8 1.0
OE1 A:GLU406 4.4 19.6 1.0
CB A:INN4 4.5 33.8 0.6
O A:HOH633 4.8 35.5 1.0
CE A:MET435 4.8 16.8 1.0
C2 A:615486 4.9 13.8 0.4
C5 A:615486 4.9 7.2 0.4
C4 A:615486 4.9 58.6 0.4
C22 A:615486 4.9 59.8 0.4
C1 A:INN4 4.9 28.9 0.6
CA A:INN4 4.9 72.2 0.6
OE2 A:GLU406 4.9 20.2 1.0

Zinc binding site 2 out of 2 in 3e8r

Go back to Zinc Binding Sites List in 3e8r
Zinc binding site 2 out of 2 in the Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Crystal Structure of Catalytic Domain of Tace with Hydroxamate Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn2

b:25.6
occ:1.00
O2 B:615486 1.9 25.6 1.0
NE2 B:HIS415 2.0 21.3 1.0
NE2 B:HIS409 2.1 20.1 1.0
O4 B:615486 2.1 21.9 1.0
NE2 B:HIS405 2.1 20.0 1.0
O B:HOH692 2.7 39.4 1.0
C3 B:615486 2.8 18.3 1.0
N2 B:615486 2.9 21.3 1.0
CE1 B:HIS415 3.0 21.5 1.0
CD2 B:HIS405 3.0 21.1 1.0
CD2 B:HIS415 3.1 20.1 1.0
CD2 B:HIS409 3.1 20.6 1.0
CE1 B:HIS409 3.1 20.5 1.0
CE1 B:HIS405 3.2 19.3 1.0
O B:HOH654 3.9 27.4 1.0
ND1 B:HIS415 4.1 22.3 1.0
C21 B:615486 4.2 31.6 1.0
CG B:HIS415 4.2 20.0 1.0
CG B:HIS405 4.2 19.1 1.0
ND1 B:HIS409 4.2 21.1 1.0
CG B:HIS409 4.2 19.9 1.0
ND1 B:HIS405 4.2 20.6 1.0
OE1 B:GLU406 4.5 21.3 1.0
O B:HOH648 4.6 35.6 1.0
CE B:MET435 4.6 17.8 1.0
O B:HOH660 4.6 32.6 1.0
C4 B:615486 4.7 26.4 1.0
C2 B:615486 4.7 21.8 1.0
C5 B:615486 4.7 19.9 1.0
C22 B:615486 4.8 29.8 1.0
OE2 B:GLU406 4.9 24.5 1.0

Reference:

R.D.Mazzola, Z.Zhu, L.Sinning, B.Mckittrick, B.Lavey, J.Spitler, J.Kozlowski, S.Neng-Yang, G.Zhou, Z.Guo, P.Orth, V.Madison, J.Sun, D.Lundell, X.Niu. Discovery of Novel Hydroxamates As Highly Potent Tumor Necrosis Factor-Alpha Converting Enzyme Inhibitors. Part II: Optimization of the S3' Pocket. Bioorg.Med.Chem.Lett. V. 18 5809 2008.
ISSN: ISSN 0960-894X
PubMed: 18835710
DOI: 10.1016/J.BMCL.2008.09.045
Page generated: Wed Dec 16 04:15:14 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy